An amazing new technology involving the delivery of cannabis compounds was presented by Perry Davidson, founder and CEO of Syqe Medical in Tel Aviv. The company, which last year assigned a cooperation and distribution agreement with the now financially ailing Teva Pharmaceutical Industries, developed for the first time an inhaler that enables the precise delivery of cannabis at the level of safety and precision of conventional drugs, similar to inhalers used for asthma. The hi-tech device, which contains an internal cartridge with 45 compartments, each containing a specific dose raw cannabis, has been used on certain patients with Health Ministry approval for about two years at Haifa’s Rambam Medical Center. The device changes the physical structure of cannabis leaves, preserving all its characteristics and enabling safe, precise and measurable dosing and delivery by inhalation, the company official said.
Read more on The Jerusalem Post here.